Vertex Pharmaceuticals Incorporated shares owned by Cullinan Associates
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Cullinan Associates
from 13F filings
Historical chart of Cullinan Associates investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Cullinan Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Cullinan Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $24M | 56k | 418.01 |
| 2023-12-31 | $24M | 58k | 406.89 |
| 2023-09-30 | $21M | 61k | 347.74 |
| 2023-06-30 | $22M | 62k | 351.91 |
| 2023-03-31 | $20M | 65k | 315.07 |
| 2022-12-31 | $19M | 65k | 288.77 |
| 2022-09-30 | $24M | 84k | 289.54 |
| 2022-06-30 | $25M | 89k | 281.79 |
| 2022-03-31 | $26M | 98k | 260.97 |
| 2021-12-31 | $22M | 99k | 219.60 |
| 2021-09-30 | $18M | 99k | 181.39 |
| 2021-06-30 | $21M | 102k | 201.63 |
| 2021-03-31 | $22M | 104k | 214.89 |
| 2020-12-31 | $22M | 94k | 236.34 |
| 2020-09-30 | $24M | 89k | 272.12 |
| 2020-06-30 | $27M | 94k | 290.31 |
| 2020-03-31 | $22M | 93k | 237.95 |
| 2019-12-31 | $20M | 91k | 218.95 |
| 2019-09-30 | $17M | 102k | 169.42 |
| 2019-06-30 | $19M | 102k | 183.38 |
| 2019-03-31 | $20M | 111k | 183.95 |
| 2018-12-31 | $19M | 117k | 165.71 |
| 2018-09-30 | $22M | 112k | 192.74 |
| 2018-06-30 | $21M | 120k | 169.96 |
| 2018-03-31 | $16M | 99k | 162.98 |
| 2017-12-31 | $15M | 98k | 149.86 |
| 2017-09-30 | $15M | 97k | 152.04 |
| 2017-06-30 | $14M | 109k | 128.87 |
| 2017-03-31 | $9.5M | 87k | 109.35 |
| 2016-12-31 | $9.2M | 125k | 73.67 |
| 2016-09-30 | $11M | 128k | 87.21 |
| 2016-06-30 | $11M | 128k | 86.02 |
| 2016-03-31 | $8.0M | 101k | 79.49 |
| 2015-12-31 | $13M | 101k | 125.83 |
| 2015-09-30 | $11M | 101k | 104.14 |
| 2015-06-30 | $12M | 101k | 123.48 |
| 2015-03-31 | $12M | 101k | 117.97 |
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated